Back to search

Article

Comparison of Neoadjuvant Chemoimmunotherapy and Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma: A Retrospective Study with 3-Year Survival Analysis

2024-06-13

Abstract excerpt

<title>Abstract</title> <p>Background Neoadjuvant chemoimmunotherapy (nCIT) for locally advanced esophageal squamous cell cancer (ESCC) has shown short-term benefits, but long-term survival outcomes are unclear. This study compares nCIT and neoadjuvant chemotherapy (nCT) in resectable ESCC. Patients and Methods: A retrospective analysis was conducted on ESCC patients who underwent nCT or nCIT followed by esopha...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c1ab6d8d-7489-5a71-af34-0237c916b73c
DOI
10.21203/rs.3.rs-4489788/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparison of Neoadjuvant Chemoimmunotherapy and Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma: A Retrospective Study with 3-Year Survival AnalysisDOI 10.21203/rs.3.rs-4489788/v1
Comparative Analysis of Clinical Outcomes Between Neoadjuvant Chemoimmunotherapy and Neoadjuvant Chemoradiotherapy in Patients with Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Retrospective StudySemantic proximity
Five-year Survival Analyses on Non-Pathological Complete Response Esophageal Squamous Cell Carcinoma Patients after Neoadjuvant Regimens plus Surgery: a Propensity Score Matching, Real-World Cohort StudySemantic proximity
Pretreatment PET/CT Radiomics Combined with Clinicopathologic Features for Recurrence-Free Survival Risk Stratification After Neoadjuvant Immunochemotherapy in Esophageal Squamous Cell Carcinoma: A Multicenter StudySemantic proximity
PD-1 Inhibitor Plus Chemotherapy Versus Chemotherapy for First-Line Treatment in Advanced Esophageal Cancer: A Systematic Review and Meta-Analysis.Semantic proximity
CT-based Radiomics for prediction of response to neoadjuvant immunochemotherapy in patients with esophageal carcinomaSemantic proximity
Outcomes of Definitive Chemoradiotherapy for Stage Iva (T4b Vs N4) Esophageal Cancer Based on the Japanese Classification System: A Retrospective Single-center Study&nbsp;Semantic proximity
Genomic alterations and dynamic molecular residual disease monitoring predict pathological response to neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma.Semantic proximity
Neoadjuvant Chemoimmunotherapy in Patients with Resectable Non-small Cell Lung Cancer.Semantic proximity
Targeted Therapies in Neoadjuvant Treatment for Gastroesophageal CancerSemantic proximity
Predictors of Survival in Esophageal Squamous Cell Carcinoma with Pathologic Major Response after Neoadjuvant Chemoradiation Therapy and Surgery: The Impact of Chemotherapy Protocols.Semantic proximity
Machine learning models predict overall survival and progression free survival of non-surgical esophageal cancer patients with chemoradiotherapy based on CT image radiomics signaturesSemantic proximity
Effects of perioperative treatment of resectable adenocarcinoma of esophagogastric junction by immunotherapy (Adebrelimab) combined with chemotherapy (XELOX): protocol for a single-center, open-labeled study (AEGIS trial, neoadjuvant immunochemotherapy)Semantic proximity
Select a neighboring publication to make it the new centre.